drugset / Trial / NCT01511367

Comparison of Flutiform, Fluticasone and Seretide in Treatment of Moderate to Severe Asthma in Paediatric Patients

NCT01511367

Phase 3 Completed 498 enrolled Mundipharma Research Limited
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This is a comparator study to assess safety and efficacy of Flutiform compared with Fluticasone pMDI and Seretide pMDI in paediatric asthma patients with moderate to severe persistent, reversible asthma.

Timeline

Start
2012-03
Primary completion
2013-09
Completion
2013-11

Drugs

EvaluationDrugModalityDoseRoute
Comparator Fluticasone Other / unclassified 50 ug Inhaled
Comparator Fluticasone propionate Other / unclassified 50 ug Inhaled
Comparator Formoterol Other / unclassified 5 ug Inhaled
Comparator Salmeterol Other / unclassified 25 ug Inhaled

Indications